Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment
Fresenius Kabi
Fresenius Kabi
Centre hospitalier Henri Mondor d'Aurillac
Debre Berhan University
Universita di Verona
University of Copenhagen
Fresenius Kabi
China Medical University Hospital
University of Uyo Teaching Hospital
International Centre for Diarrhoeal Disease Research, Bangladesh
FrieslandCampina WAMCO Nigeria PLC
Coordinación de Investigación en Salud, Mexico
M.D. Anderson Cancer Center
University of South Florida
Alliance for International Medical Action
Medecins Sans Frontieres, Netherlands
Makerere University